Clarithromycin Tablet, Film Coated
Product Images NDC 50090-1830

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 50090-1830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Clarithromycin Fig1)

A line graph comparing the proportion of subjects surviving over time between Clarithromycin and Placebo groups. The x-axis represents days since randomization, and the y-axis shows the proportion surviving. Clarithromycin shows a higher survival proportion throughout the period up to around 650 days.*

FDA Label Image

Chemical Structure (Clarithromycin Str)

Chemical structure of clarithromycin, showing its molecular framework with multiple rings, including lactone and sugar moieties, and various functional groups such as hydroxyl, methyl, and methoxy groups.*

FDA Label Image

Label Image (Lbl500901830)

Clarithromycin 500 mg film-coated tablets label from A-S Medication Solutions. The label states each film-coated tablet contains 500 mg of Clarithromycin USP. Storage instructions specify 68 to 77 degrees Fahrenheit. The package contains 30 tablets. The label includes NDC 50090-1830-1 and mentions dosage information is on the packet insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.